Baroncini, Damiano http://orcid.org/0000-0003-4234-8956
Ghezzi, Angelo
Guaschino, Clara
Moiola, Lucia
Filippi, Massimo
Ianniello, Antonio
Pozzilli, Carlo
Lanzillo, Roberta
Brescia-Morra, Vincenzo
Margoni, Monica
Gallo, Paolo
Callari, Graziella
Grimaldi, Luigi
Lus, Giacomo
Calabrese, Massimiliano
Simone, Marta
Marfia, Girolama Alessandra
Rasia, Sarah
Cargnelutti, Daniela
Comi, Giancarlo
Zaffaroni, Mauro
Trojano, Maria
Centonze, Diego
Capra, Ruggero
Capobianco, Marco
Laroni, Alice
Uccelli, Antonio
Gallo, Antonio
Patti, Francesco
Danni, Maura Chiara
Gasperini, Claudio
Coniglio, Gabriella
,
Article History
Received: 28 March 2022
Accepted: 12 June 2022
First Online: 4 July 2022
Declarations
:
: <b>Authors</b>Damiano Baroncini received travel grants for participation at national/international congresses and compensations for consulting/speaking/scientific publications activities from Sanofi Genzyme, Teva, Merck, Biogen, Roche, Almirall, and Novartis.Angelo Ghezzi received honoraria for speaking from Almirall, Biogen Idec, Merck Serono, Novartis, Genzyme and Sanofi-Aventis and for consultancy from Merck Serono, Biogen Idec, Teva, F Hoffmann-La Roche and Novartis.Clara Guaschino has served on scientific advisory boards and received support for travel and congress attendance from Biogen, Novartis, Almirall, Sanofi-Genzyme, Merck-Serono.Lucia Moiola has received honoraria for speaking and for partecipating to advisory board from: Biogen-Idec; Merck; Sanofi-Genzyme; Novartis; Celgene; Roche.Massimo Filippi is Editor-in-Chief of the Journal of Neurology and Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; received compensation for consulting services and/or speaking activities from Almiral, Alexion, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, MerckSerono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).Antonio Ianniello reports no disclosures.Carlo Pozzilli received consulting and lecture fees from Sanofi-Aventis, Biogen Idec, Bayer Schering, Merck Serono, and Novartis. He also received research funding from Novartis, Sanofi-Aventis, Merck Serono, and Bayer Schering.Roberta Lanzillo has received honoraria from Merck, Novartis, Roche, Sanofi-Genzyme and Teva.Vincenzo Brescia-Morra has received research grants from the Italian MS Society and Roche and honoraria from Bayer, Biogen, Merck, Mylan, Novartis, Roche, Sanofi-Genzyme and Teva.Monica Margonireports grants and personal fees from Sanofi Genzyme, Merck Serono, Novartis and Almirall. She was awarded a MAGNIMS-ECTRIMS fellowship in 2020.Paolo Gallo has been a consultant and member of Advisory Board for Biogen Italy, Sanofi-Genzyme, Merck-Serono, Almirall, Roche, Bristol-Meyer-Squibb and Novartis-Farma; has received funding for travel and speaker honoraria from Merck-Serono, Biogen Italy, Sanof-Genzyme, Novartis-Pharma, Roche, Almirall; has received research support from Biogen Italy, Merk-Serono, Sanofi Genzyme, Roche, Novartis.Graziella Callari reports no disclosures.Luigi Grimaldi has received travel funding and/or speaker honoraria from Biogen, Merck Serono, Novartis, Sanofi, and Teva and research support from Biogen and Merck Serono.Giacomo Lus received personal compensation for speaking or consultancy from Biogen, Teva, Genzyme, Merck, Novartis, Almirall, Merz, and Ipsen.Massimiliano Calabrese received speaker honoraria and consulting fees from Biogen, Bristol Myers Squibb, Celgene, Genzyme, Merck Serono, Novartis, and Roche and received research support from the Progressive MS Alliance and the Italian Minister of Health.Marta Simone reports no disclosures.Marfia Girolama Alessandra is an Advisory Board member of Biogen Idec,Genzyme, Merck-Serono, Novartis, Teva and received honoraria forspeaking or consultation fees from Almirall, Bayer Schering, BiogenIdec, Merck Serono, Novartis, Sanofi-Genzyme, Roche, Mylan, Teva. Sheis the principal investigator in clinical trials for Biogen Idec,Merck Serono, Novartis, Roche, Sanofi-Genzyme, Teva.Sarah Rasia reports no disclosures Daniela Cargnelutti reports no disclosures.Giancarlo Comi reports personal fees from Novartis, Teva Pharmaceutical Industries Ltd, Teva Italia Srl, Sanofi Genzyme, Genzyme Corporation, Genzyme Europe, Merck KGgA, Merck Serono SpA, Celgene Group, Biogen Idec, Biogen Italia Srl, F. Hoffman-La Roche, Roche SpA, Almirall SpA, Forward Pharma, Medday, Excemed.Mauro Zaffaroni has received honoraria for consulting or lecturing and travel grants from: Alexion, Almirall, Biogen, Celgene, Janssen-Cilag, Merck, Novartis, Sanofi-Genzyme.<b>Collaborators</b>Maria Trojano has served on scientific Advisory boards for Biogen, Novartis, Roche, Merck , BMS and Genzyme; has received speaker honoraria from Biogen, Roche, Sanofi, Merck, Genzyme and Novartis; and has received research grants for her Institution from Biogen, Merck, Novartis and Roche.Diego Centonze is an advisory board member for Almirall, Bayer, Biogen, GW Pharmaceuticals, Merck, Novartis, Roche, Sanofi, and Teva, and received honoraria for speaking or consultation fees from Almirall, Bayer, Biogen, GW Pharmaceuticals, Novartis, Roche, Sanofi, and Teva. He is also the principal investigator in clinical trials for Bayer, Biogen, Merck, Mitsubishi, Novartis, Roche, Sanofi, and Teva. His preclinical and clinical research was supported by grants from Bayer, Biogen, Celgene (BMS), Merck, Novartis, Roche, Sanofi, and Teva.Ruggero Capra reports lecture fees and/or travel grants from Novartis, Biogen, Roche, Celgene and Merck.Marco Capobianco received personal fees for advisory board and/or sponsored meeting from Biogen, Merck, Roche, Novartis, Celgene-Bristol, Janssen, Beck Dickinson, Alexion. He also received research grant from FISM, Roche, Novartis.Alice Laroni received grants or contracts from Italian Ministry of University, Ministry of Health; received consulting fees from Merck, Biogen, Roche, Novartis, Bristol-Myers Squibb Pharma EEIG; received honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Mercks, Biogen, Roche, Novartis, Bristol-Myers Squibb Pharma EEIG.Antonio Uccelli received grants (to his Institution) from FISM, Biogen, Roche, Alexion, Merck Serono; participated on a Data Safety Monitoring Board or Advisory Board (to his Institution) for BD, Biogen, Iqvia, Sanofi, Roche, Alexion, Bristol Myers Squibb.Antonio Gallo received personal compensation for speaking and consultancy from Biogen, Bristol Myers Squibb, Merck-Serono, Mylan, Novartis, Roche, Sanofi-Genzyme, and Teva.Francesco Patti received personal compensation for serving on advisory board or speaking ad ECM events by Alexion, Almirall, Bayer, Biogen, Bristol Meyers&Squibb, Janssen, Merck, Novartis, Roche, Sanofi. He also received research grants by Almirall, Biogen, Merck, and Roche, FISM, MIUR and Reload Onlus Association.Maura Chiara Danni reports no disclosures.Claudio Gasperini has received compensation for consulting from Bayer HealthCare and Biogen and as a speaker for lectures from Biogen, Bayer HealthCare, Genzyme, Merck Serono, Novartis and Teva.Gabriella Coniglio reports no disclosures.
: This study received approval from the ethical committee of the coordinating center (Multiple Sclerosis Center, Gallarate Hospital, ASST Valle Olona).